An evaluation of the validity of measureing salivary oxycodone concentrations for pharmacokinetic studies in patients [ 2008 - 2009 ]

Research Grant

Researchers: Prof Janet Hardy (Principal investigator) ,  A/Pr Bruce Charles ,  A/Pr Ross Norris

Brief description In many countries, oxycodone is replacing morphine as the opioid of first choice for the treatment of moderate to severe pain. Despite this, very little is known about how the drug is processed in the body or how its ability to control pain is affected by such factors as other drugs, age or organ function. Studies to determine this usually require multiple blood tests from individual patients over set time periods. Our team is able to measure drug levels in saliva and has shown this to be a valid substitute for the measurement of drug levels in blood. Furthermore, one of us has developed a computer modelling system that shows how drugs are handled in the body using only a few samples from each patient. Palliative care patients are generally frail and unwell. We are reluctant to expose them to invasive tests such as repeated blood sampling. If we can prove that saliva sampling is as good as blood sampling, we will have identified a simple non-invasive means of greatly increasing our knowledge of oxycodone and how it behaves in individual patients. This in turn may allow us to tailor drug doses according to the unique characteristics of each patient and to optimise their pain control.

Funding Amount $AUD 49,135.00

Funding Scheme NHMRC Strategic Awards

Notes Palliative Care Research